ID
45139
Descripción
Principal Investigator: Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA MeSH: Prostatic Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000330 Seven primary prostate cancers and their paired normal counterparts were DNA-sequenced on a massively parallel sequencing platform. This approach was taken to investigate the genomes for mutations and genomic alterations that would be undetectable by lower-resolution methods. As result, tumors containing chains of balanced rearrangements that occurred within or adjacent to known cancer genes were discovered.
Link
Palabras clave
Versiones (3)
- 8/10/22 8/10/22 - Adrian Schulz
- 12/10/22 12/10/22 - Adrian Schulz
- 12/10/22 12/10/22 - Adrian Schulz
Titular de derechos de autor
Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA
Subido en
12 de octubre de 2022
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs000330 The Genomic Complexity of Primary Human Prostate Cancer
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject sources, consent form, and affection status of participants affected with prostate cancer.
- Sample ID, subject ID, and sample sources of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor sample characteristics, and demography of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor and normal blood sample characteristics, and subject ID of participants affected with prostate cancer.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject sources, consent form, and affection status of participants affected with prostate cancer.
- Sample ID, subject ID, and sample sources of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor sample characteristics, and demography of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor and normal blood sample characteristics, and subject ID of participants affected with prostate cancer.
C1512693 (UMLS CUI [1,2])